Microfluidic device for primary tumor spheroid isolation

Jiaojiao Zhou, Jimmy Su, Xiaotong Fu, Lei Zheng, Zhizhong Yin

Research output: Contribution to journalArticle

Abstract

Background: Traditional two-dimensional (2-D) monolayer cell culture is vastly different from in vivo physiological conditions, which can lead to inaccurate or insufficient data in areas where response and efficacy within humans are being investigated, such as drug discovery, pathology studies, etc. Misleading results arise from two main disadvantages of monolayer cell culture. First, after several passages, cell lines lose many features from their original in vivo state. Second, the morphology of cells cultured in a monolayer is much different from the cell morphology in three-dimensional (3-D) in vivo conditions, thus resulting in altered cellular function. Three-dimensional multi-cellular spheroids, on the other hand, are a better representation of in vivo physiological conditions while still retaining many of the in vitro cell culture advantages. Primary spheroids freshly isolated from tissue samples are especially ideal for cell-based assays by avoiding the two problems of 2-D monolayer cell culture. Methods: In this paper, we report a microfluidic device for primary tumor spheroid isolation. Pancreatic tumor samples from mice were used in the experiments. Results: We successfully isolated primary tumor spheroids from the pancreatic tumor samples and were able to maintain the spheroids in culture for up to two weeks. Conclusions: This novel microfluidic device may promote and advance the isolation of primary tumor spheroids for future drug testing and interrogation of tumor characteristics.

Original languageEnglish (US)
Article number22
JournalExperimental Hematology and Oncology
Volume6
Issue number1
DOIs
StatePublished - Aug 7 2017

Fingerprint

Lab-On-A-Chip Devices
Cell Culture Techniques
Neoplasms
Cellular Spheroids
Drug Discovery
Cultured Cells
Pathology
Cell Line

Keywords

  • Cancer
  • Cell Culture
  • Microfluidics
  • Organoid
  • Primary Cell
  • Spheroid

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Microfluidic device for primary tumor spheroid isolation. / Zhou, Jiaojiao; Su, Jimmy; Fu, Xiaotong; Zheng, Lei; Yin, Zhizhong.

In: Experimental Hematology and Oncology, Vol. 6, No. 1, 22, 07.08.2017.

Research output: Contribution to journalArticle

Zhou, Jiaojiao ; Su, Jimmy ; Fu, Xiaotong ; Zheng, Lei ; Yin, Zhizhong. / Microfluidic device for primary tumor spheroid isolation. In: Experimental Hematology and Oncology. 2017 ; Vol. 6, No. 1.
@article{762046c52c1244eaa50087812e67036e,
title = "Microfluidic device for primary tumor spheroid isolation",
abstract = "Background: Traditional two-dimensional (2-D) monolayer cell culture is vastly different from in vivo physiological conditions, which can lead to inaccurate or insufficient data in areas where response and efficacy within humans are being investigated, such as drug discovery, pathology studies, etc. Misleading results arise from two main disadvantages of monolayer cell culture. First, after several passages, cell lines lose many features from their original in vivo state. Second, the morphology of cells cultured in a monolayer is much different from the cell morphology in three-dimensional (3-D) in vivo conditions, thus resulting in altered cellular function. Three-dimensional multi-cellular spheroids, on the other hand, are a better representation of in vivo physiological conditions while still retaining many of the in vitro cell culture advantages. Primary spheroids freshly isolated from tissue samples are especially ideal for cell-based assays by avoiding the two problems of 2-D monolayer cell culture. Methods: In this paper, we report a microfluidic device for primary tumor spheroid isolation. Pancreatic tumor samples from mice were used in the experiments. Results: We successfully isolated primary tumor spheroids from the pancreatic tumor samples and were able to maintain the spheroids in culture for up to two weeks. Conclusions: This novel microfluidic device may promote and advance the isolation of primary tumor spheroids for future drug testing and interrogation of tumor characteristics.",
keywords = "Cancer, Cell Culture, Microfluidics, Organoid, Primary Cell, Spheroid",
author = "Jiaojiao Zhou and Jimmy Su and Xiaotong Fu and Lei Zheng and Zhizhong Yin",
year = "2017",
month = "8",
day = "7",
doi = "10.1186/s40164-017-0084-3",
language = "English (US)",
volume = "6",
journal = "Experimental Hematology and Oncology",
issn = "2162-3619",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Microfluidic device for primary tumor spheroid isolation

AU - Zhou, Jiaojiao

AU - Su, Jimmy

AU - Fu, Xiaotong

AU - Zheng, Lei

AU - Yin, Zhizhong

PY - 2017/8/7

Y1 - 2017/8/7

N2 - Background: Traditional two-dimensional (2-D) monolayer cell culture is vastly different from in vivo physiological conditions, which can lead to inaccurate or insufficient data in areas where response and efficacy within humans are being investigated, such as drug discovery, pathology studies, etc. Misleading results arise from two main disadvantages of monolayer cell culture. First, after several passages, cell lines lose many features from their original in vivo state. Second, the morphology of cells cultured in a monolayer is much different from the cell morphology in three-dimensional (3-D) in vivo conditions, thus resulting in altered cellular function. Three-dimensional multi-cellular spheroids, on the other hand, are a better representation of in vivo physiological conditions while still retaining many of the in vitro cell culture advantages. Primary spheroids freshly isolated from tissue samples are especially ideal for cell-based assays by avoiding the two problems of 2-D monolayer cell culture. Methods: In this paper, we report a microfluidic device for primary tumor spheroid isolation. Pancreatic tumor samples from mice were used in the experiments. Results: We successfully isolated primary tumor spheroids from the pancreatic tumor samples and were able to maintain the spheroids in culture for up to two weeks. Conclusions: This novel microfluidic device may promote and advance the isolation of primary tumor spheroids for future drug testing and interrogation of tumor characteristics.

AB - Background: Traditional two-dimensional (2-D) monolayer cell culture is vastly different from in vivo physiological conditions, which can lead to inaccurate or insufficient data in areas where response and efficacy within humans are being investigated, such as drug discovery, pathology studies, etc. Misleading results arise from two main disadvantages of monolayer cell culture. First, after several passages, cell lines lose many features from their original in vivo state. Second, the morphology of cells cultured in a monolayer is much different from the cell morphology in three-dimensional (3-D) in vivo conditions, thus resulting in altered cellular function. Three-dimensional multi-cellular spheroids, on the other hand, are a better representation of in vivo physiological conditions while still retaining many of the in vitro cell culture advantages. Primary spheroids freshly isolated from tissue samples are especially ideal for cell-based assays by avoiding the two problems of 2-D monolayer cell culture. Methods: In this paper, we report a microfluidic device for primary tumor spheroid isolation. Pancreatic tumor samples from mice were used in the experiments. Results: We successfully isolated primary tumor spheroids from the pancreatic tumor samples and were able to maintain the spheroids in culture for up to two weeks. Conclusions: This novel microfluidic device may promote and advance the isolation of primary tumor spheroids for future drug testing and interrogation of tumor characteristics.

KW - Cancer

KW - Cell Culture

KW - Microfluidics

KW - Organoid

KW - Primary Cell

KW - Spheroid

UR - http://www.scopus.com/inward/record.url?scp=85027174936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027174936&partnerID=8YFLogxK

U2 - 10.1186/s40164-017-0084-3

DO - 10.1186/s40164-017-0084-3

M3 - Article

C2 - 28794917

AN - SCOPUS:85027174936

VL - 6

JO - Experimental Hematology and Oncology

JF - Experimental Hematology and Oncology

SN - 2162-3619

IS - 1

M1 - 22

ER -